pXPR_120 Citations (3)

Originally described in: Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens.
Najm FJ, Strand C, Donovan KF, Hegde M, Sanson KR, Vaimberg EW, Sullender ME, Hartenian E, Kalani Z, Fusi N, Listgarten J, Younger ST, Bernstein BE, Root DE, Doench JG Nat Biotechnol. 2018 Feb;36(2):179-189. doi: 10.1038/nbt.4048. Epub 2017 Dec 18. PubMed Journal

---

Articles Citing pXPR_120

Articles
Radioresistance, DNA Damage and DNA Repair in Cells With Moderate Overexpression of RPA1. Velegzhaninov IO, Belykh ES, Rasova EE, Pylina YI, Shadrin DM, Klokov DY. Front Genet. 2020 Jul 31;11:855. doi: 10.3389/fgene.2020.00855. eCollection 2020. PubMed
CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network. Morelli E, Gulla' A, Amodio N, Taiana E, Neri A, Fulciniti M, Munshi NC. Methods Mol Biol. 2021;2348:189-204. doi: 10.1007/978-1-0716-1581-2_13. PubMed
Novel regulators of PrPC biosynthesis revealed by genome-wide RNA interference. Heinzer D, Avar M, Pease DP, Dhingra A, Yin JA, Schaper E, Dogancay B, Emmenegger M, Spinelli A, Maggi K, Chincisan A, Mead S, Hornemann S, Heutink P, Aguzzi A. PLoS Pathog. 2021 Oct 27;17(10):e1010013. doi: 10.1371/journal.ppat.1010013. eCollection 2021 Oct. PubMed

If you have published an article using this material, please email us at to have your article added to this page.